Toggle site contrast Toggle Contract

Starting Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors – for patients with Type 2 Diabetes

View or download a PDF of the patient information leaflet for people with Type 2 diabetes starting Sodium-Glucose Co-transporter 2 (SGLT2) inhibitors

This information is provided via the Buckinghamshire, Oxfordshire & Berkshire West (BOB) website Medicines Optimisation Team page.

The Medicines Optimisation Team supports healthcare professionals across Buckinghamshire, Oxfordshire & Berkshire West (BOB) to optimise medicines use and ensure the right treatment choices are made.